跳至主要内容
临床试验/CTRI/2025/05/086500
CTRI/2025/05/086500尚未招募Unknown

A prospective, single-arm, open-label, multi-center, observational,post-market clinical follow-up study to evaluate the safety andperformance of i-Tack A sterile absorbable powered mesh fixationdevice in subjects intended for surgical mesh fixation to soft tissue invarious open or laparoscopic surgical procedures.

Meril Life Sciences Pvt Ltd1 个研究点 分布在 1 个国家目标入组 198 人开始时间: 2025年5月22日最近更新:

试验速览

阶段
Unknown
状态
尚未招募
发起方
入组人数
198
试验地点
1
主要终点
1.Recurrence rate of hernia

研究概览

简要总结

Title: A prospective, single-arm, open-label, multi-center, observational,post-market clinical follow-up study to evaluate the safety andperformance of i-Tack A sterile absorbable powered mesh fixationdevice in subjects intended for surgical mesh fixation to soft tissue invarious open or laparoscopic surgical procedures.

Short Title i-Tack A

Protocol ID, Version& Date: MES/i-Tack A_Version_1.0.0_12-Dec-2024

Study device: i-Tack A (Sterile Absorbable Powered Mesh Fixation Device)

Indication: i-Tack(TM) A is intended for the fixation of surgical mesh to soft tissuein various minimally invasive and open general surgical andlaparoscopic procedures, such as hernia repair.Objective This study aims to evaluate the safety and performance of i-Tack(TM) A.

Study Design: A prospective, single-arm, open-label, multi-center, observational,post-market clinical follow-up study.

Study population: All the consecutive subjects will undergo fixation of surgical mesh tosoft tissue in various minimally invasive and open general surgicaland laparoscopic procedures, such as hernia repair using i-Tack(TM) A

Rationale of the Study: Mesh fixation devices are of fundamental importance in surgical outcomes. Hence, the presentstudy is to evaluate the safety and performance of a sterile absorbable powered mesh fixationdevice composed of the delivery system and i-Tack™ A mesh fixation device in the fixation ofsurgical mesh to soft tissue in various minimally invasive and open general surgical andlaparoscopic procedures, such as hernia repair

.

研究设计

研究类型
Observational

入排标准

年龄范围
18.00 Year(s) 至 99.00 Year(s)(—)
性别
All

入选标准

  • 1.Subjects who will undergo soft tissue minimally invasive and open general surgical and laparoscopic procedures, such as hernia repair by using i-Tack(TM) A sterile absorbable powered mesh fixation device.
  • Subject will undergo i-Tack(TM) A sterile, absorbable, powered mesh fixation device.
  • Subject must be willing and able to provide written Informed Consent by signing and dating the IRB or EC approved Informed Consent form.
  • Subject is not able to write on behalf of the Subject, the Subject`s LAR (Legally acceptable representative) can fill out the informed consent.
  • Adults and elderly Subjects.
  • Subject who willing and able to comply with scheduled postoperative clinical evaluations.

排除标准

  • 1.Subjects requiring extended approximation of tissues under stress.
  • Subjects with tissues that have a direct anatomic relationship to major vascular structures.
  • Subjects who underwent ischemic or necrotic tissue surgery.
  • Subjects with tissue that cannot be visually inspected for hemostasis.
  • Subjects with specific drug allergies or past comorbidities.
  • Subjects unfit for general anesthesia.
  • Pregnant women.

结局指标

主要结局

1.Recurrence rate of hernia

时间窗: 1.Time Frame: 7 days ± 2 days, | 15 days ± 2 days, 30 days ± 7 days, 3 months ± 15 days, 6 | months ± 30 days, 12 months ± 30 days | 2. Time Frame: Discharge, 7 days ± 2 days, 15 days ± 2 days, 30 days ± 7 days, 3 months ± 15 days, 6 months ± 30 days, 12 months ± 30 days

2.Adverse Events

时间窗: 1.Time Frame: 7 days ± 2 days, | 15 days ± 2 days, 30 days ± 7 days, 3 months ± 15 days, 6 | months ± 30 days, 12 months ± 30 days | 2. Time Frame: Discharge, 7 days ± 2 days, 15 days ± 2 days, 30 days ± 7 days, 3 months ± 15 days, 6 months ± 30 days, 12 months ± 30 days

3. Complications

时间窗: 1.Time Frame: 7 days ± 2 days, | 15 days ± 2 days, 30 days ± 7 days, 3 months ± 15 days, 6 | months ± 30 days, 12 months ± 30 days | 2. Time Frame: Discharge, 7 days ± 2 days, 15 days ± 2 days, 30 days ± 7 days, 3 months ± 15 days, 6 months ± 30 days, 12 months ± 30 days

次要结局

  • 1.Intra-operative complications(2.Re-intervention)

研究者

发起方
Meril Life Sciences Pvt Ltd
申办方类型
Other [Medical Device Company ]

研究点 (1)

Loading locations...

相似试验